---
title: "levobunolol - Ocular hypertension"
sidebar: mydoc_sidebar
permalink: levobunololocularhypertension3.html
toc: false 
---

{% include image.html file="levobunololocularhypertension3.png" alt="levobunololocularhypertension3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002040 | levobunolol | Drug |
| UniProt:P07550 | Beta-2 adrenergic receptor | Protein |
| MESH:D000242 | cyclic adenosine monophosphate | ChemicalSubstance |
| UBERON:0010427 | ciliary processes | GrossAnatomicalStructure |
| UBERON:0001796 | aqueous humor | GrossAnatomicalStructure |
| HP:0007906 | intraocular pressure | PhenotypicFeature |
| MESH:D009798 | Ocular hypertension | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Levobunolol | DECREASES ACTIVITY OF | Beta-2 Adrenergic Receptor |
| Beta-2 Adrenergic Receptor | INCREASES ABUNDANCE OF | Cyclic Adenosine Monophosphate |
| Cyclic Adenosine Monophosphate | LOCATED IN | Ciliary Processes |
| Ciliary Processes | DECREASES SYNTHESIS OF | Aqueous Humor |
| Aqueous Humor | NEGATIVELY REGULATES | Intraocular Pressure |
| Intraocular Pressure | TREATS | Ocular Hypertension |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01210#mechanism-of-action](https://go.drugbank.com/drugs/DB01210#mechanism-of-action){:target="_blank"}